Screener
Humacyte HUMA Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
Revenue$467.0KMiss by $882.3K
EPS-$0.13In line
Revenue estimate$1.3M
EPS estimate-$0.13
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$769.4K
EPS estimate-$0.09
Versus estimates
Revenue
FAQ
- When did Humacyte report Q4 2025 earnings?
- Humacyte (HUMA) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were Humacyte's Q4 2025 revenue and EPS?
- Humacyte reported revenue of $467.0K and eps of $-0.13 for Q4 2025.
- Did Humacyte beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $1.3M by $882.3K. EPS beat the consensus estimate of $-0.13 by $0.00.
- How did Humacyte's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 93.5% from $7.2M a year earlier and eps grew 18.8% from $-0.16.
- Where can I find Humacyte's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001818382-26-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.
